Cargando…
The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology
A new threat to global health re-emerged with monkeypox’s advent in early 2022. As of November 10, 2022, nearly 80,000 confirmed cases had been reported worldwide, with most of them coming from places where the disease is not common. There were 53 fatalities, with 40 occurring in areas that had neve...
Autores principales: | Qudus, Muhammad Suhaib, Cui, Xianghua, Tian, Mingfu, Afaq, Uzair, Sajid, Muhammad, Qureshi, Sonia, Liu, Siyu, Ma, June, Wang, Guolei, Faraz, Muhammad, Sadia, Haleema, Wu, Kailang, Zhu, Chengliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391643/ https://www.ncbi.nlm.nih.gov/pubmed/37533932 http://dx.doi.org/10.3389/fcimb.2023.1196699 |
Ejemplares similares
-
Corrigendum: The prospective outcome of the Monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology
por: Qudus, Muhammad Suhaib, et al.
Publicado: (2023) -
β-Glucan Induces Training Immunity to Promote Antiviral Activity by Activating TBK1
por: Wang, Guolei, et al.
Publicado: (2023) -
Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly
por: Li, Zhiqiang, et al.
Publicado: (2023) -
The monkeypox diagnosis, treatments and prevention: A review
por: Khattak, Saadullah, et al.
Publicado: (2023) -
Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
por: Ajmal, Amar, et al.
Publicado: (2023)